drugset / Trial / NCT01440881

Does Nesiritide Provide Renal Protection

NCT01440881

Phase 2 Completed 37 enrolled University of Florida
RandomizedParallel-groupTriple-blindPrevention

Summary

This project evaluates whether nesiritide, human recombinant brain natriuretic peptide, confers renal protection during cardiovascular surgery by attenuating the inflammatory response.

Timeline

Start
2010-04
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nesiritide Protein / enzyme biologic 0.01 ug/kg

Indications